News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
SALES GROWTH ACCELERATION PLAN TO TRIPLE SIZE OF ONCOLOGIST/HOSPITAL SALES TEAM IN 2018 NEW HAVEN, Conn., Jan. 16, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics firm Precipio, Inc. (NASDAQ:PRPO) has appointed Douglas Sites to the new position of Vice President of Sales where he will be responsible for executing Precipio’s Pathology Services sales plan, targeting oncologists... Read more
Global research consortium leverages DNAnexus cloud-based platform to scale analyses for the world’s animal kingdom January 16, 2018 08:00 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–DNAnexus, the global leader in genome informatics and data management, today announced that the Genome10K’s (G10K) Vertebrate Genomes Project (VGP) will utilize the DNAnexus Platform in assembling and analyzing... Read more
As President, Dawn Barry will be responsible for leading operations, communicating and implementing company mission, and guiding overall strategy, direction, and growth at Luna DNA. SAN DIEGO, Jan. 15, 2018 /PRNewswire/ — Luna DNA, the first and only genomic and medical research knowledge base powered by the blockchain and owned by its community, announced today Dawn Barry as president. In... Read more
–Optimized sample preparation protocols and software algorithms enable high-quality, cost-effective de novo assembly for agrigenomics and other non-human applications at scale.– PLEASANTON, CA.—January 15, 2018—10x Genomics, Inc., a company focused on accelerating genomic discovery, today launched a new version of their de novo assembly solution to provide the fastest most cost-effective solution for creating high-quality de novo assemblies at scale for... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today the launch of the iSeq™ 100 Sequencing System. The new, next-generation sequencing (NGS) system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab. The combination of the company’s proven sequencing by synthesis (SBS) chemistry, along with the complementary metal-oxide-semiconductor... Read more
–MGI’s BGISEQ-500RS Genetic Sequencer, Forthcoming MGISEQ Genetic Sequencers Compatible with 10x Genomics Solutions– PLEASANTON, CA. and SHENZHEN, CHINA —January 8, 2018—10x Genomics, Inc. and MGI, a subsidiary of BGI, today announced that the BGISEQ-500RS genetic sequencer has met the rigorous standards of the new 10x Genomics Compatible Program. MGI will also ensure that the MGISEQ... Read more
Goal set to exceed $140 million of NGS-related sales in 2018, up from over $115 million in 2017 New Enterprise Genomics Services to offer gene panel customization capabilities to customers GeneReader NGS System plans include enhanced chemistry, more powerful gene panels Hilden, Germany, and Germantown, Maryland, January 8, 2018 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt... Read more
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced today announced that on Thursday, January 25, 2018, after market close, the Company will release fourth quarter 2017 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and KingMed Diagnostics (SSE: 603882.SS) today announced an agreement to jointly develop novel oncology and hereditary disease testing applications utilizing Illumina’s next-generation sequencing (NGS) technology. The collaboration is a significant step toward China Food and Drug Administration (CFDA) review and approval, and serves as a starting point to deliver... Read more
NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) — Precipio, Inc. (NASDAQ:PRPO), announced today the launch of the second new version of its ICE-COLD PCR™ (ICP) enrichment kit, used to identify resistance mutations in non-small cell lung cancer (NSCLC) using liquid biopsies. As part of the transformation of ICP to be platform-agnostic, this kit has... Read more